Friday, May 23, 2025
HomeAsiaTOPVISION Eye Specialist Berhad Celebrates Transfer of Listing on ACE Market of...

TOPVISION Eye Specialist Berhad Celebrates Transfer of Listing on ACE Market of Bursa Malaysia at 18.18% Premium

Date:

Related stories

Advancecon Continues Contract Win Momentum with RM68.5 Million Contract from Sime Darby Property

Advancecon Holdings Berhad (前进控股有限公司) (“Advancecon” or “the Group”) (Bursa:...

AmanahRaya REIT Delivers Strong Q1 FY2025 Performance with 69.0% Growth in Realised Income Before Tax

AmanahRaya Real Estate Investment Trust (“AmanahRaya REIT”) reported its financial...

Orgabio Unveils Encouraging Revenue Growth of 24.85% to RM28.0 Million in Q3 FY2025

Orgabio Holdings Berhad (“Orgabio” or the “Company”) a leading instant...

Advancecon Secures RM47.5 Million Contract for Gerbil Data Centre Development in Port Dickson

Advancecon Holdings Berhad (前进控股有限公司) (“Advancecon” or “the Group”) (Bursa: 5281),...

DC Healthcare Kicks Off FY2025 with 89% Revenue Growth in Q1FY2025

DC Healthcare Holdings Berhad ("DC Healthcare" or the "Group"), a...

KUALA LUMPUR, 16 DECEMBER 2024 – TOPVISION Eye Specialist Berhad (“TOPVISION” or the “Company”), an experienced player in medical eye care services in Malaysia, proudly marked its official transfer of listing today on the ACE Market of Bursa Malaysia Securities Berhad (“Bursa Securities”). TOPVISION shares debuted at RM0.390 per share, reflecting a 18.18% premium over its issue price of RM0.330.

TOPVISION is listed under the stock name “TOPVISN” with the stock code “0332”.

L-R: Ms. Lim May Wan, Independent Non-Executive Director, Ms. Soong Yoke Voon, Chief Operating Officer, Dr. Peter Chong Kuok Siong, CEO and Executive Director, Mr. Lee Geok Ai, Independent Non-Executive Chairman, Datuk Kenny Liew Hock Nean, Executive Vice Chairman, Professor Datin Dr. Angela Loo Voon Pei, Consultant Ophthalmologist, Ms. Tan Mei Hui, Chief Financial Officer & Mr. Tan Kah Poh, Independent Non-Executive Director of TOPVISION Eye Specialist Berhad

As one of the pioneer in accessible and advanced eye care services which was listed on the LEAP Market in 2018, TOPVISION has established itself as a trusted provider in Malaysia’s healthcare landscape. The Company operates 11 ambulatory care centres (“ACCs”) nationwide, offering a wide range of services from general eye care to subspecialty treatments, catering to both local and international patients.

The successful public offering raised RM17.9 million, which will be strategically allocated to support the Company’s expansion and operational goals. Specifically, RM7.9 million will be used to fund the development of TOPVISION International, a multidisciplinary specialist tertiary eye ACC with an additional RM5.0 million to be allocated for the establishment of TOPVISION Kuala Terengganu and TOPVISION Tawau, while RM0.5 million is set aside for enhancing existing facilities via purchase of medical machines. The remaining RM4.5 million has been allocated for listing expenses.

Datuk Kenny Liew Hock Nean, Executive Vice Chairman of TOPVISION, shared his enthusiasm, stating, “This transfer of listing marks a significant milestone in TOPVISION’s journey, reflecting our unwavering commitment to delivering quality and accessible eye care services across Malaysia. It symbolises not only the culmination of our hard work but also the confidence the market has in our strategic vision and growth potential. With this transition, we aim to strengthen our presence in Malaysia’s eye healthcare sector, expand our service network, and elevate the standards of patient care to new heights.”

Hong Leong Investment Bank Berhad is the Principal Adviser, Sponsor, Sole Underwriter and Sole Bookrunner.

Jiro Komyoji
Jiro Komyoji
Live positive, share positivity, be mindful of others. Sometimes there is a backstory worth hearing.

Latest stories